TSLA Inc.

NASDAQ
Back to all articles
TSLA Inc. stock analysis TSLA overview
Slightly Bullish +25

Tesla stock is surging around 3%, but analysts are growing cautious

📈 Tesla shares rose 2.8% to $378.06 in early Monday trading amid broader market gains.

🤖 CEO Elon Musk announced 'Terafab,' a joint venture with xAI and SpaceX for large-scale semiconductor manufacturing.

💰 The project requires tens of billions in initial investment, with equipment spending projected at $20 billion in 2026.

📅 Initial production is targeted for late 2027, with volume output expected by 2028.

⚡ The facility aims to produce chips at a terawatt scale, equivalent to powering one billion advanced AI chips annually.

🔬 Terafab will focus on cutting-edge two-nanometer chip technology for autonomous vehicles and robotics.

🚀 Up to 80% of the facility's output could be deployed in space for SpaceX AI computing workloads.

📉 Analyst Trip Chowdhry issued a sell recommendation with a $150 price target for 2026.

⚠️ Barclays maintained an Equalweight rating but warned costs could significantly exceed current expectations.

💸 Some analysts estimate capital expenditure requirements could exceed $100 billion over the long term.

Bullish Signals
  • Tesla shares are surging 2.8% to $378.06, indicating strong early trading momentum despite broader market volatility.
  • The Terafab initiative represents a strategic vertical integration of chip production to secure supply for AI and autonomous driving.
  • The project targets cutting-edge two-nanometer technology, positioning Tesla at the forefront of semiconductor manufacturing.
  • A significant portion of output (up to 80%) is planned for space-based computing, diversifying revenue streams beyond Earth.
  • Bullish investors view the massive capital expenditure as a necessary investment to maintain long-term leadership in AI infrastructure.
Risk Factors
  • Analyst Trip Chowdhry issued a sell recommendation with a $150 price target for 2026, arguing the AI-driven investment thesis has weakened.
  • Barclays warned that the actual cost of the Terafab project could be significantly higher than current expectations.
  • Capital expenditure requirements are estimated by some analysts to potentially exceed $100 billion over time.
  • Investor enthusiasm may outpace execution, a pattern observed in past technology cycles according to analyst Trip Chowdhry.
Full Analysis
Tesla shares rose 2.8% to $378.06 in early Monday trading, driven by a broader market rebound linked to easing geopolitical tensions between Washington and Tehran. While the Dow Jones jumped 648 points and major indices gained over 1%, Tesla's specific momentum is increasingly tied to expectations of future technologies rather than its core automotive operations. The primary catalyst for attention was CEO Elon Musk's announcement of 'Terafab,' a massive joint venture between Tesla, xAI, and SpaceX to vertically integrate semiconductor manufacturing. The initiative aims to produce advanced chips at a terawatt scale, targeting late 2027 for initial production and volume output by 2028 to address anticipated shortages in AI applications. Wall Street reactions remain mixed regarding the ambitious project's financial implications. Analyst Trip Chowdhry issued a sell recommendation with a $150 price target for 2026, citing weakened investment thesis compared to past tech cycles. Conversely, Barclays maintained an Equalweight rating but warned that costs could exceed expectations, with some estimates suggesting capital expenditure requirements might surpass $100 billion over time. Despite the caution, bullish investors view the high spending as necessary to secure long-term leadership in AI infrastructure. The facility plans to utilize cutting-edge two-nanometer technology, with up to 80% of output potentially deployed for SpaceX's space-based computing workloads, marking a significant strategic pivot toward vertical integration and artificial intelligence.